Enea Romania has delivered the first version of the Cell Gazer, the high-level software engineering project that involves the creation and implementation of complex algorithms for recording and evaluating 2D and 3D images data of human cell specimens identified as suspected to cause dysplasia or cancer.
The objective of the project – which is already under development in the second version which will include more advanced features – is to document, manage and integrate data from diagnostic tests at cytology and tissue levels. The software solution will provide to the medical specialists the data to determine the correct diagnosis based on an extensive and much faster analysis.
This software engineering project in the development of Enea Romania teams in Craiova and Bucharest is an important project for the medical industry with a major impact on reducing the human error factor in collecting data on lung cancer. Detection of lung cancer is traditionally done with biopsy.
This software engineering project is in development of Enea Romania teams from Craiova and Bucharest, and is an important project for the medical industry with a major impact on reducing the human error factor in collecting data.
Important: following the evaluation of the “Cell Gazer: AI medical project” project, businessmagazin.ro included Enea Romania in the “Top 2018 Most Innovative Companies in Romania”.